Improved survival with phosphodiesterase-5 inhibitor use in men with male-predominant cancers: real-world large database study
{{output}}
Introduction: Phosphodiesterase-5 (PDE5) inhibitors, commonly prescribed for erectile dysfunction, may exhibit immunomodulatory properties by reducing myeloid-derived suppressor cell activity and enhancing T-cell responses. This ... ...
